ArticleNeuropharmacology2026
Chronic morphine differentially impacts glutamatergic synaptic plasticity in the ventral tegmental area of adult versus adolescent mice.
Article in Neuropharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
Abstract
Opioids mediate the majority of drug overdose-related deaths in the United States. Opioid-induces addictive behaviors in part via manipulation of excitatory synaptic plasticity of ventral tegmental area (VTA) dopamine cells by targeting presynaptic mu opioid receptors (MORs). Recent data demonstrate VTA GABAergic cells also exhibit excitatory long-term depression (LTD) plasticity that is cannabis susceptible. Here we identify expression of presynaptic MORs at excitatory inputs to VTA GABA cells of male/female adolescent and adult mice using electrophysiology, motivating further examination of morphine impact on synaptic plasticity of these understudied cells. Long-term (7-10 days) intraperitoneal injection of morphine eliminated both LTD and MOR agonist-induced synaptic depression in adolescent mice. Surprisingly, in adult mice chronic morphine eliminated LTD in only ∼50% of VTA GABA cells. Seven-day withdrawal following morphine treatment reversed LTD elimination in all adolescents GABA cells, but not in adults. Next, as LTD is cannabinoid receptor 1 (CB1)-dependent and endogenous opioid and cannabinoid systems have signaling overlap, we examined MOR influence on LTD. While MOR antagonist naloxone did not block LTD, pre-exposure of MOR agonist DAMGO occluded LTD, suggesting CB1 and MOR crosstalk. Collectively, this demonstrates morphine alteration of VTA GABA cell function and plasticity that potentially correlates to dependence and withdrawal, as well as age-dependent morphine impact. Further examination of opioid dependence mediated by the inhibitory reward circuit that considers age-dependence will be essential when considering targets for therapeutic interventions aimed at mitigating opioid addiction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.